{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:52:09Z","timestamp":1791996729335,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103620"],"award-info":[{"award-number":["P20GM103620"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015362","name":"Amicus Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ymthe.2020.09.033","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T08:54:42Z","timestamp":1600937682000},"page":"162-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Tyler B.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon J.","family":"Brudvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob T.","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Langin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa D.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Timm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha S.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Meyerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibi","family":"Likhite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.09.033_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0387-7604(88)80075-5","article-title":"Neuronal ceroid-lipofuscinoses in childhood","volume":"10","author":"Santavuori","year":"1988","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymthe.2020.09.033_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","article-title":"Batten disease: past, present, and future","volume":"5","author":"Rider","year":"1988","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"10.1016\/j.ymthe.2020.09.033_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ajmg.1320420428","article-title":"Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)","volume":"42","author":"Palmer","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymthe.2020.09.033_bib5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41556-018-0228-7","article-title":"CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis","volume":"20","author":"di Ronza","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nbd.2012.04.018","article-title":"Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice","volume":"47","author":"Kuronen","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2020.09.033_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10048-005-0024-y","article-title":"Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: another genetic hit in the Mediterranean","volume":"7","author":"Cannelli","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ymthe.2020.09.033_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1399-0004.2009.01285.x","article-title":"Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis","volume":"77","author":"Reinhardt","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymthe.2020.09.033_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24953\/turkjpediatr.2004.2761","article-title":"Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies","volume":"46","author":"Top\u00e7u","year":"2004","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.ymthe.2020.09.033_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/humu.21012","article-title":"A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function","volume":"30","author":"Vantaggiato","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2020.09.033_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.pediatrneurol.2007.01.008","article-title":"A novel mutation of the CLN8 gene: is there a Mediterranean phenotype?","volume":"36","author":"Zelnik","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/13868","article-title":"The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8","volume":"23","author":"Ranta","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2020.09.033_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1750-3639.2000.tb00255.x","article-title":"Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis","volume":"10","author":"Herva","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1528-1157.1995.tb01616.x","article-title":"Northern epilepsy syndrome: clinical course and the effect of medication on seizures","volume":"36","author":"Hirvasniemi","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymthe.2020.09.033_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12881-018-0535-7","article-title":"Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants","volume":"19","author":"Gao","year":"2018","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymthe.2020.09.033_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/humu.20018","article-title":"Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy","volume":"23","author":"Ranta","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2020.09.033_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1097-4547(19971001)50:1<123::AID-JNR13>3.0.CO;2-C","article-title":"Dietary carnitine supplements slow disease progression in a putative mouse model for hereditary ceroid-lipofuscinosis","volume":"50","author":"Katz","year":"1997","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ymthe.2020.09.033_bib18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/cmdc.200600144","article-title":"Optimized synthesis of AMPA receptor antagonist ZK 187638 and neurobehavioral activity in a mouse model of neuronal ceroid lipofuscinosis","volume":"1","author":"Elger","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ymthe.2020.09.033_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.expneurol.2004.03.006","article-title":"Clenbuterol retards loss of motor function in motor neuron degeneration mice","volume":"187","author":"Zeman","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2020.09.033_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/01677068609106858","article-title":"Autosomal dominance in a late-onset motor neuron disease in the mouse","volume":"3","author":"Messer","year":"1986","journal-title":"J.\u00a0Neurogenet."},{"key":"10.1016\/j.ymthe.2020.09.033_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1006\/exer.1993.1169","article-title":"Retinal degeneration in motor neuron degeneration (mnd) mutant mice","volume":"57","author":"Messer","year":"1993","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2020.09.033_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.410330408","article-title":"Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten\u2019s disease)","volume":"33","author":"Bronson","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbr.2005.02.024","article-title":"Behavioral assessment in mouse models of neuronal ceroid lipofuscinosis using a light-cued T-maze","volume":"161","author":"Wendt","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymthe.2020.09.033_bib25","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.eye.6701770","article-title":"Progression of early postnatal retinal pathology in a mouse model of neuronal ceroid lipofuscinosis","volume":"19","author":"Seigel","year":"2005","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.ymthe.2020.09.033_bib26","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ymthe.2019.06.015","article-title":"Gene therapy corrects brain and behavioral pathologies in CLN6-Batten disease","volume":"27","author":"Cain","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.09.033_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.09.033_bib29","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1523\/JNEUROSCI.1635-16.2016","article-title":"Self-complementary AAV9 gene delivery partially corrects pathology associated with juvenile neuronal ceroid lipofuscinosis (CLN3)","volume":"36","author":"Bosch","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2020.09.033_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ajmg.1320570251","article-title":"Genetics of primary and timing effects in the mnd mouse","volume":"57","author":"Messer","year":"1995","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymthe.2020.09.033_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","article-title":"The neuronal ceroid-lipofuscinoses","volume":"62","author":"Haltia","year":"2003","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbadis.2015.11.014","article-title":"Reactive gliosis in the pathogenesis of CNS diseases","volume":"1862","author":"Pekny","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2020.09.033_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0006-8993(02)02470-8","article-title":"The development of behavioral abnormalities in the motor neuron degeneration (mnd) mouse","volume":"937","author":"Bolivar","year":"2002","journal-title":"Brain Res."},{"issue":"39","key":"10.1016\/j.ymthe.2020.09.033_bib34","first-page":"1787","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","author":"Guyenet","year":"2010","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2020.09.033_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.33588\/rn.6804.2018217","article-title":"Congenital CLN8 disease of neuronal ceroid lipofuscinosis: a novel phenotype","volume":"68","author":"Pesaola","year":"2019","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib36","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.09.033_bib37","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2020.09.033_bib38","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.09.033_bib39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10545-011-9446-x","article-title":"Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis","volume":"35","author":"Roberts","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2020.09.033_bib40","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1089\/hgtb.2012.120","article-title":"Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis","volume":"23","author":"Sondhi","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2020.09.033_bib41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.23545","article-title":"Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis","volume":"71","author":"Macauley","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.09.033_bib43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.09.033_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnana.2014.00042","article-title":"Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse","volume":"8","author":"Schuster","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ymthe.2020.09.033_bib45","doi-asserted-by":"crossref","first-page":"e67680","DOI":"10.1371\/journal.pone.0067680","article-title":"Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain","volume":"8","author":"Chakrabarty","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.09.033_bib46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/gt.2016.24","article-title":"Axonal transport of AAV9 in nonhuman primate brain","volume":"23","author":"Green","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.09.033_bib47","doi-asserted-by":"crossref","first-page":"e0176526","DOI":"10.1371\/journal.pone.0176526","article-title":"A tailored mouse model of CLN2 disease: a nonsense mutant for testing personalized therapies","volume":"12","author":"Geraets","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620304901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620304901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:30:27Z","timestamp":1791995427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620304901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1525001620304901"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.033","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.05.079350","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020","name":"copyright","label":"Copyright"}]}}